MediXall Group, Inc.
MDXL
$0.0035
$0.00026.06%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 18.40% | 16.22% | 36.98% | 49.32% | 1.95% |
| Total Depreciation and Amortization | -20.23% | 161.90% | 30.00% | 66.67% | 16,950.00% |
| Total Amortization of Deferred Charges | -93.62% | 19.11% | 1,061.54% | 8,300.00% | -- |
| Total Other Non-Cash Items | -84.17% | 292.83% | 28.08% | -57.26% | 46.14% |
| Change in Net Operating Assets | 872.90% | -70.63% | -71.75% | 66.52% | -26.15% |
| Cash from Operations | 66.34% | 70.61% | 59.40% | 65.97% | 39.87% |
| Capital Expenditure | -- | -- | -- | -- | -75.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -275.00% |
| Total Debt Issued | -60.10% | -68.05% | -58.95% | -15.38% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -- | -100.00% | -99.74% | -95.86% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -61.61% | -68.05% | -60.61% | -67.29% | -25.49% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 101.52% | 90.95% | -76.68% | -102.72% | 74.76% |
